Breath Analysis to Diagnose Lung Cancer

Last updated: April 10, 2025
Sponsor: University Hospital, Lille
Overall Status: Completed

Phase

N/A

Condition

Lung Cancer

Cancer

Non-small Cell Lung Cancer

Treatment

Collection of volatile organic compounds during exhalation

Clinical Study ID

NCT03250390
2017_05
PHRCI_2016
2017-A00932-51
  • Ages > 18
  • All Genders

Study Summary

Determination of volatile organic compounds to discriminate patients with lung cancer from healthy smokers and non-smokers healthy subjects.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with histologically proven lung cancer

Controls:

  • healthy smoker or non-smoker subjects

  • without respiratory diseases excepted chronic obstructive pulmonary disease.

Exclusion

Exclusion Criteria:

  • history of cancer other than lung cancer within 5 years before inclusion

  • oral or facial malformation

  • incomprehension of maneuvers for the collection

Study Design

Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: Collection of volatile organic compounds during exhalation
Phase:
Study Start date:
April 29, 2019
Estimated Completion Date:
April 29, 2024

Connect with a study center

  • Hôpital Calmette, CHU

    Lille,
    France

    Site Not Available

  • Institut Pasteur - Centre de Prévention et d'Education à la Santé (CPES)

    Lille, 59000
    France

    Site Not Available

  • Hopital Victor Provo

    Roubaix,
    France

    Site Not Available

  • Centre Hospitalier de Saint Quentin

    Saint-Quentin,
    France

    Site Not Available

  • Chu Amiens Salouël

    Salouël,
    France

    Site Not Available

  • Ch Seclin - Seclin

    Seclin,
    France

    Site Not Available

  • Clinique Teissier

    Valenciennes,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.